至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization.

J Cell Mol Med.. 2017-08; 
Li Y,Zhu P,Verma A,Prasad T,Deng H,Yu D,Li Q.
Products/Services Used Details Operation
Catalog Products ... above. EAU was induced by immunization with 50 μg of IRBP (161–180) (SGIPYIISYLHPGNTILHVD) (Genscript, Piscataway, NJ, USA) with CFA (Sigma-Aldrich) (1:1 vol/vol) subcutaneously [27] 3 weeks after viral administration. … Get A Quote

摘要

Elevated vascular endothelial growth factor (VEGF) and complement activation are implicated in the pathogenesis of different ocular diseases. The objective of this study was to investigate the hypothesis that dual inhibition of both VEGF and complement activation would confer better protection against ocular inflammation and neovascularization. In this study, we engineered a secreted chimeric VEGF inhibitor domain (VID), a complement inhibitor domain (CID) and a dual inhibitor (ACVP1). Vectors expressing these three inhibitors were constructed and packaged into AAV2 (sextY-F) particles. The expression and secretion of the proteins were validated by Western blot. The effects of these inhibitors expressed from AA... More

关键词

AAV ; age-related macular degeneration; angiogenesis; autoimmune uveitis; choroidal neovascularization; complement; gene therapy; ocular inflammation; uveitis; vascular endothelial growth factor